Open Access

Expression of miR-23a and miR-135 and tumor markers in gastric cancer patients and the significance in diagnosis

  • Authors:
    • Likui Yin
    • Guangxiao Xu
    • Yuntao Zhu
    • Yongqiang Wang
  • View Affiliations

  • Published online on: October 1, 2019     https://doi.org/10.3892/ol.2019.10943
  • Pages: 5853-5858
  • Copyright: © Yin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Correlation between the expression of miR-23a and miR-135 and tumor markers in gastric cancer patients and their significance in diagnosis was investigated. A total of 78 patients with gastric cancer admitted to Dongying People's Hospital from July 2015 to June 2017 were enrolled, and 80 healthy patients were selected as the control group during the same period. The expression levels of miR-23a and miR-135 in the serum of the two groups were detected by RT-qPCR, and the expression levels of tumor markers CEA and carbohydrate antigen 199 (CA199) were detected by ELISA. The receiver operating characteristic curve and area under the curve (AUC) were used to evaluate the diagnostic efficacy of miR-23a and miR-135 as diagnostic indicators. There was no significant difference between the observation and the control group (P>0.05). The expression levels of miR-23a and miR-135 in the observation group were significantly higher than those in the control group (P<0.05). The expression levels of CEA and CA199 in serum of patients in the observation group were significantly higher than those in the control group (P<0.05). Pearson's correlation test showed that the expression levels of miR-23a and miR-135 were positively correlated with CEA and CA199 (P<0.05). The specificity, sensitivity and AUC of miR-23a in the diagnosis of gastric cancer were 67.95, 87.50 and 0.805%, respectively. The specificity, sensitivity and AUC of miR-135 in the diagnosis of gastric cancer were 73.08, 82.50 and 0.824%, respectively. Both could be used in the diagnosis of gastric cancer. In conclusion, miR-23a and miR-135 are highly expressed in gastric cancer patients and positively correlated with tumor markers, which can be used in diagnosis for gastric cancer.

Related Articles

Journal Cover

December 2019
Volume 18 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Yin, L., Xu, G., Zhu, Y., & Wang, Y. (2019). Expression of miR-23a and miR-135 and tumor markers in gastric cancer patients and the significance in diagnosis. Oncology Letters, 18, 5853-5858. https://doi.org/10.3892/ol.2019.10943
MLA
Yin, L., Xu, G., Zhu, Y., Wang, Y."Expression of miR-23a and miR-135 and tumor markers in gastric cancer patients and the significance in diagnosis". Oncology Letters 18.6 (2019): 5853-5858.
Chicago
Yin, L., Xu, G., Zhu, Y., Wang, Y."Expression of miR-23a and miR-135 and tumor markers in gastric cancer patients and the significance in diagnosis". Oncology Letters 18, no. 6 (2019): 5853-5858. https://doi.org/10.3892/ol.2019.10943